These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 317434)

  • 1. Cell-mediated immune status in patients of non-Hodgkin's lymphoma (NHL): an evaluation by skin tests, blastogenic transformation of lymphocytes and T-cell count.
    Misra NC; Singh VP; Saxena KC; Saxena RP; Agarwal CG
    Cell Mol Biol Incl Cyto Enzymol; 1979; 25(3):185-9. PubMed ID: 317434
    [No Abstract]   [Full Text] [Related]  

  • 2. Delayed cutaneous hypersensitivity and blood lymphocyte count in advanced Hodgkin's and non-Hodgkin's lymphomas.
    Gupta S; Seth SK; Udupa KN; Sen PC; Rastogi BL
    Ann Chir Gynaecol; 1980; 69(2):79-83. PubMed ID: 7377739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus-specific immune response and the cellular immune status of malignant lymphoma.
    ten Napel CH; van Egten-Bijker J; Halie MR; Langenhuysen MM; The TH
    J Clin Lab Immunol; 1980 Nov; 4(3):145-51. PubMed ID: 6259357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blastogenic transformation of lymphocytes following phytohaemagglutinin treatment in vitro in malignant lymphomas. I. Hodgkin's disease. (Correlation with immunity response of the cellular type and with the clinical status).
    Libánský J; Lukásová M; Pinosová I
    Neoplasma; 1973; 20(1):51-60. PubMed ID: 4702205
    [No Abstract]   [Full Text] [Related]  

  • 5. Peripheral lymphocyte count and suppopulations of T and B lymphocytes in benign and malignant diseases.
    Lee YT
    Surg Gynecol Obstet; 1977 Mar; 144(3):435-50. PubMed ID: 300179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of radiochemotherapy and splenectomy on cellular immunity in long-term survivors of Hodgkin's disease and non-Hodgkin's lymphoma.
    Steele R; Han T
    Cancer; 1978 Jul; 42(1):133-9. PubMed ID: 667791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The pathophysiology of malignant lymphoma from the hematological point of view. 3. Changes in peripheral blood lymphocyte count and the recovery of cell-mediated immune function after therapy of T-, B-malignant lymphomas and Hodgkin's disease].
    Kinoshita K; Amagasaki T; Momita S; Ikeda S; Ichimaru M; Kamihira S
    Nihon Ketsueki Gakkai Zasshi; 1986 Aug; 49(5):1068-80. PubMed ID: 3788434
    [No Abstract]   [Full Text] [Related]  

  • 8. SPLEEN/PATHOL.
    Bukowski RM; Noguchi S; Hewlett JS; Deodhar S
    Am J Clin Pathol; 1976 Jan; 65(1):30-9. PubMed ID: 1082240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
    Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
    J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoration of cellular immune response by levamisole in patients with Hodgkin's disease.
    Levo Y; Rotter V; Ramot B
    Biomedicine; 1975 Jun; 23(6):198-200. PubMed ID: 1082352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral lymphocyte count in untreated non-Hodgkin's lymphoma patients and their lymphographic findings.
    Matsubara S; Suzuki S; Horiuchi J; Shibuya H; Maeda M; Miyamoto H
    Lymphology; 1980 Dec; 13(4):192-6. PubMed ID: 6970866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunological data in the clinical evaluation of Hodgkin's diseases].
    Burchardt K
    Z Gesamte Inn Med; 1981 Nov; 36(21):840. PubMed ID: 6977241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro evidence of normal lymphocyte function in some patients with Hodgkin's disease and negative delayed cutaneous hypersensitivity.
    Churchill WH; Rocklin RR; Moloney WC; David JR
    Natl Cancer Inst Monogr; 1973 May; 36():99-106. PubMed ID: 4583000
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunodeficiencies in Hodgkin's disease. Part I: T cell-mediated immunity.
    Gupta S
    Clin Bull; 1981; 11(2):58-65. PubMed ID: 6459892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the blast cell in childhood non-Hodgkin's lymphoproliferative malignancies.
    Coccia PF
    Semin Oncol; 1977 Sep; 4(3):287-96. PubMed ID: 335518
    [No Abstract]   [Full Text] [Related]  

  • 16. Reduced natural killer cell activity in non-hodgkin's lymphoma.
    Neri A; Brugiatelli M; Ozger Topuz U; Astaldi G
    Boll Ist Sieroter Milan; 1981 Nov; 60(5):394-407. PubMed ID: 7041921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blastogenic transformation of lymphocytes following phytohaemagglutinin treatment in vitro in malignant lymphomas. II. Reticulosarcoma. (Correlation with the immunity reaction of the cellular type and the clinical status).
    Libánský J; Sedlácková M; Pinosová I
    Neoplasma; 1973; 20(1):61-7. PubMed ID: 4573872
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunological follow-up of non-Hodgkin's lymphoma (NHL) in children.
    Bogusławska-Jaworska J; Chybicka A; Pisarek J
    Arch Immunol Ther Exp (Warsz); 1981; 29(6):733-8. PubMed ID: 6983870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular immune reactions in human acute leukemia.
    Herberman RB
    Hamatol Bluttransfus; 1974; 14():107-18. PubMed ID: 4615044
    [No Abstract]   [Full Text] [Related]  

  • 20. Immune status in untreated patients with lymphoreticular malignancy--a multifactorial study.
    Hancock BW; Bruce L; Sugden P; Ward AM; Richmond J
    Clin Oncol; 1977 Mar; 3(1):57-63. PubMed ID: 324686
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.